Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 447,646 | 41,954 | N/A | N/A |
| Marketable Securities | 230,415 | 313,862 | N/A | N/A |
| Receivables | 75,000 | N/A | N/A | N/A |
| Other current assets | 7,654 | 0 | 0 | 0 |
| TOTAL | $770,100 | $360,536 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 6,250 | 8,094 | N/A | N/A |
| Other Non-Current Assets | 23,479 | 24,438 | 0 | 0 |
| TOTAL | $29,729 | $32,532 | $N/A | $N/A |
| Total Assets | $799,829 | $393,068 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 6,351 | 6,991 | 0 | 0 |
| Accrued Expenses | 5,760 | 3,746 | N/A | N/A |
| TOTAL | $13,632 | $11,986 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 22,904 | 561,520 | 0 | 0 |
| TOTAL | $22,904 | $561,520 | $N/A | $N/A |
| Total Liabilities | $36,536 | $573,506 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 90,400 | N/A | N/A | N/A |
| Common Shares | 90 | 4 | N/A | N/A |
| Retained earnings | -404,228 | -189,482 | N/A | N/A |
| Other shareholders' equity | 64 | 325 | 0 | 0 |
| TOTAL | $763,293 | $-180,438 | $N/A | $N/A |
| Total Liabilities And Equity | $799,829 | $393,068 | $0 | $0 |